Monitoring and modulation of Epstein-Barr virus loads in pediatric transplant patients

Pediatric Transplantation

Volumn 7, Issue 4, 2003, Pages 305-314

  Orentas, Rimas J ^a   Schauer Jr , Dennis W ^a   Ellis, Frederick W ^a   Walczak, Joanna ^a   Casper, James T ^a   Margolis, David A ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Bone marrow transplantation; Epstein Barr virus; Human herpesvirus 4; Lymphoproliferative disorders; Polymerase chain reaction; Viral load

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD20; RITUXIMAB; UNCLASSIFIED DRUG; VIRUS DNA;

ADOLESCENT; ARTICLE; BONE MARROW TRANSPLANTATION; CHILD; EPSTEIN BARR VIRUS; HEART TRANSPLANTATION; HUMAN; HUMAN CELL; INFANT; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; MORTALITY; POLYMERASE CHAIN REACTION; POSTTRANSPLANT LYMPHOMA; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; SEROLOGY; TRANSPLANTATION; VIRUS INFECTION; VIRUS LOAD;

BONE MARROW TRANSPLANTATION; DNA, VIRAL; GENOME, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPHOMA; LYMPHOPROLIFERATIVE DISORDERS; MONITORING, PHYSIOLOGIC; ORGAN TRANSPLANTATION; POLYMERASE CHAIN REACTION; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDIES; VIRAL LOAD;

EID: 0043237359     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3046.2003.00090.x     Document Type: Article

References (25)

1. KIEFF E. Epstein-Barr virus and its replication. In: FIELDS BN, KNIPE DM, HOWLEY PM, eds. Fields Virology, 3rd edn. Philadelphia: Lippincott-Raven Publishers, 1996: pp. 2343-2396.
2. RICKINSON AB, KIEFF E. Epstein-Barr virus. In: FIELDS BN, KNIPE DM, HOWLEY PM, eds. Fields Virology, 3rd edn. Philadelphia: Lippincott-Raven Publishers 1996, 2397-2446.
3. SWINNEN LJ, COSTANZO-NORDIN MR, FISHER SG, et al. Increased incidence of lymphoproliferative disorder after immunosupression with the monoclonal antibody OKT3 in cardiac-transplant recipients. New Engl J Med 1990: 323: 1723-1728.
4. MICALLEF INM, CHHANABHI M, GASCOYNE RD, et al. Lymphoproliferative disorders following allogeneic bone marrow transplantation: the Vancouver experience. Bone Marrow Transpl 1998: 22: 981-987.
5. CURTIS RE, TRAVIS LB, ROWLINGS PA, et al. Risk of lymphoproliferative disorders after bone marrow transplantation: A multi-institutional study. Blood 1999: 94: 2208-2216.
6. HOSHINO Y, KIMURA K, KUZUSHIMA K, et al. Early intervention in post-transplant lymphoproliferative disorders based on Epstein-Barr viral load. Bone Marrow Transpl 2000: 26: 199-201.
7. LUCAS KG, BURTON RL, ZIMMERMAN SE, et al. Semiquantitative Epstein-Barr virus (EBV) polymerase chain reaction for the determination of patients at risk for EBV-induced lymphoproliferative disease after stem cell transplantation. Blood 1998: 91: 3654-3661.
8. GREEN M, CACCIARELLI TV, MAZARIEGOS GV, et al. Serial Measurement of Epstein-Barr viral load in peripheral blood in pediatric liver transplant recipients during treatment for post-transplant lymphoproliferative disease. Transplantation 1998: 66: 1641-1644.
9. GREEN M, MICHAELS MG, WEBBER SA, ROWE DT, REYES J. The Management of Epstein-Barr virus associated post-transplant lymphoproliferative disorders in pediatric solid organ transplant recipients. Pediatr Transplant 1999: 3: 271-281.
10. ORENTAS RJ. Determination of Epstein-Barr virus (EBV) load by RT-PCR and cellular dilution. Molecular and Cellular Probes 1998: 12: 427-430.
11. ORENTAS RJ, ROSKOPF SJ, CASPER JT, GETTS RC, NILSEN TW. Detection of Epstein-Barr virus EBER sequence in post-transplant lymphoma patients with DNA dendrimers. J Virol Methods 1999: 77: 153-163.
12. RIDDLER SA, BREINIG MC, MCKNIGHT JLC. Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients. Blood 1994: 84: 972-984.
13. SAVOIE A, PERPÉTE C, CARPENTIER L, JONCAS J, ALFIERI C. Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disease. Blood 1994: 83: 2715-2722.
14. VAN ESSER JWJ, NIESTERS HGM, VAN DER HOLT B, et al. Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation. Blood 2002: 99: 4364-4369.
15. BENKERROU M, JAIS J-P, LEBLOND V, et al. Anti-B-cell monoclonal antibody treatment of severe posttransplant B-lymphoproliferative disorder: prognostic factors and long-term outcome. Blood 1998: 92: 3137-3147.
16. YANG J, FLINN IW, MURRAY PG, et al. Characterization of Epstein-Barr virus-infected B cells in patients with posttransplantation lymphoproliferative disease: disappearance after rituximab therapy does not predict clinical response. Blood 2000: 96: 4055-4063.
17. HOWE JG, SHU M-D. Epstein-Barr virus small RNA (EBER) genes: unique transcription units that combine RNA polymerase II and III promoter elements. Cell 1989: 57: 825-834.
18. ARRAND JR, RYMO L. Characterization of the major Epstein-Barr virus-specific RNA in Burkitt lymphoma-derived cells. J Virol 1982: 41: 376-389.
19. BARLETTA JM, KINGMA DW, LING Y, CHARACHE P, MANN RB, AMBINDER RF. Rapid in Situ hybridization for the diagnosis of latent Epstein-Barr virus infection. Mol Cell Probe 1993: 7: 105-109.
20. BRANDSMA J, MILLER G. Nucleic acid spot hybridization: rapid quantitative screening of lymphoid cell lines for Epstein-Barr viral DNA. Proc Natl Acad Sci USA 1980: 77: 6851-6855.
21. ROONEY CM, SMITH CA, NG CYC, et al. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet 1995: 345: 9-13.
22. ORENTAS RJ, LEMAS MV, MULLIN MJ, COLOMBANI PM, SCHWARZ K, AMBINDER RF. Feasibility of cellular adoptive immunotherapy for Epstein-Barr virus-associated lymphomas using haploidentical donors. J Hematother 1998: 7: 257-261.
23. HAQUE T, ALMOT PL, HELLING N, et al. Reconstitution of EBV-specific T cell immunity in solid organ transplant recipients. J Immunol 1998: 160: 6204-6209.
24. HESLOP HE, NG CYC, LI C, et al. Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes. Nat Med 1996: 2: 551-5.
25. CAMPE H, JAEGER G, ABOU-AJRAM C, et al. Serial detection of Epstein-Barr virus DNA in sera and peripheral blood leukocyte samples of pediatric renal allograft recipients with persistent mononucleosis-like symptoms defines patients at risk to develop post-transplant lymphoproliferative disease. Pediatr Transplant 2003: 7: 46-52.